ASBPW vs GRWG

Over the past 5 years, Aspire Biopharma Holdings, Inc.

(ASBPW) delivered a total return of -81. 9%, compared to -96. 7% for GrowGeneration Corp. (GRWG). Over 10 years, the gap is even starker: GRWG returned -75. 7% versus ASBPW's -81. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), GrowGeneration Corp.

(GRWG) is the lower-risk stock at 1. 27β versus Aspire Biopharma Holdings, Inc. 's 3. 15β — meaning ASBPW is approximately 147% more volatile than GRWG relative to the S&P 500.

On earnings-per-share growth, the picture is similar: GrowGeneration Corp.

grew EPS 51. 2% year-over-year, compared to -381. 5% for Aspire Biopharma Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

GrowGeneration Corp.

(GRWG) is the more profitable company, earning -14. 9% net margin versus -16351. 8% for Aspire Biopharma Holdings, Inc. — meaning it keeps -14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GRWG leads at -15. 7% versus -10314. 0% for ASBPW. At the gross margin level — before operating expenses — ASBPW leads at 45. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, GrowGeneration Corp.

(GRWG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 27)). Aspire Biopharma Holdings, Inc. (ASBPW) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GRWG: -75. 7%, ASBPW: -81. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ASBPW (Healthcare) and GRWG (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.